Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, highlighting the importance of reaching all patients regardless of socioeconomic status, and wishes readers well during the holiday season.
Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, highlighting the importance of reaching all patients regardless of socioeconomic status, and wishes readers well during the holiday season.
Rania Emara explains the social barriers that socioeconomically affected rural groups experience with precision medicine and provides some insight into possible solutions.
Rania Emara explains the social barriers that socioeconomically affected rural groups experience with precision medicine and provides some insight into possible solutions.
A systematic literature review by Stephen J. Freedland, MD, and colleagues summarizes the current evidence relating to social determinants of health beyond race and survival in patients with metastatic prostate cancer.
A systematic literature review by Stephen J. Freedland, MD, and colleagues summarizes the current evidence relating to social determinants of health beyond race and survival in patients with metastatic prostate cancer.
Simon R. Davies, MBBCh, and colleagues investigate the impact of HealthPathways on management and primary care clinicians in a musculoskeletal radiology department.
Simon R. Davies, MBBCh, and colleagues investigate the impact of HealthPathways on management and primary care clinicians in a musculoskeletal radiology department.
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
The Clinical Pathways Congress + Cancer Care Business Exchange annual meeting was held in Boston, October 6-8, 2023. Topics included the role of AI in oncology, challenges in clinical trial recruitment, and more.
In the June 2022 issue of the Journal of Clinical Pathways, there were errors in the article by Davids et al. The online version of the article has been updated.
In the June 2022 issue of the Journal of Clinical Pathways, there were errors in the article by Davids et al. The online version of the article has been updated.
For the August 2023 Clinical Pathways Forum, Stephen B. Edge, MD, addressed the forum with an update on the clinical pathways program at Roswell Park Comprehensive Cancer Center.
For the August 2023 Clinical Pathways Forum, Stephen B. Edge, MD, addressed the forum with an update on the clinical pathways program at Roswell Park Comprehensive Cancer Center.
This installment of the Transformative Employer Trends column explores how employers can educate employees about clinical pathways and potentially shift their negative impressions on pathways.
This installment of the Transformative Employer Trends column explores how employers can educate employees about clinical pathways and potentially shift their negative impressions on pathways.
Mike Edgeworth, MD, and Michael Hoffman discuss how providers and payers can better collaborate by using the quadruple aim to improve the patient experience, improve health outcomes, and reduce payer cost.
Mike Edgeworth, MD, and Michael Hoffman discuss how providers and payers can better collaborate by using the quadruple aim to improve the patient experience, improve health outcomes, and reduce payer cost.
Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.
Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.
This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.
This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.
In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...
In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...
This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...
This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...
In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.
In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.
Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.
Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.
In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.
In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.
NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.